1. Exploring the potential of drug repurposing for liver diseases: A comprehensive study
   Fares E.M. Ali et al, 2024, Life Sciences CrossRef
2. Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twist‐mediated CD10 expression
   Ming‐Hsien Chien et al, 2018, Environmental Toxicology CrossRef
3. Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways
   Menna S. Zeyada et al, 2020, Life Sciences CrossRef
4. Stress Conditions Induced by Locoregional Therapies Stimulate Enrichment and Proliferation of Liver Cancer Stem Cells
   Yuchen Huo et al, 2019, Journal of Vascular and Interventional Radiology CrossRef
5. Niclosamide—A promising treatment for COVID‐19
   Shivani Singh et al, 2022, British Journal of Pharmacology CrossRef
6. Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells
   Minoru Tomizawa et al, 2018, Oncology Letters CrossRef
7. Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain
   N. G. R. Dayan Elshan et al, 2019, Medicinal Research Reviews CrossRef